Dr Amir Aref of the Dana-Farber Cancer Institute will be sharing how short-term culture of organotypic patient tumor spheroids derived from patient xenografts in AIM chips predicts in vivo response of targeted therapies at AACR 2018 on Sunday 350pm 15th April (see the full abstract & details at this link)
3 Comments
Sarah Ouadah
25/4/2018 16:59:14
Hello
Reply
Kuan Chee Mun
26/4/2018 09:14:40
Hi Sarah,
Reply
Sarah Ouadah
26/4/2018 15:29:39
Thank you dear professor for your answer.
Reply
Leave a Reply. |
Subscribe to AIM Biotech's mailing list
This website and its content is copyright of AIM Biotech Pte. Ltd. © AIM Biotech Pte. Ltd. 2020. All rights reserved. |